Abstract:As part of an ongoing prospective study to correlate mother and infant outcome with social isolation during pregnancy, the Schedule for Affective Disorders, SADS-C, was administered to twenty-seven psychotic patients late in pregnancy. Extensive standardized evaluation of life stresses and social supports included a Prenatal Interview with sixty items relating to demographics, drug use, health and obstetrical history, family involvement and development expectations of the infant, and a thirty-item Difficult Li… Show more
“…Chang and Renshaw reported an amelioration of symptoms during pregnancy (17). Krener and others found that women with schizophrenia received and required less medication to control their thought disorder when they were pregnant (18). W Can J Psychiatry, Vol 47, No 5, June 2002…”
Section: Symptom Variation Across the Menstrual Cycle During Pregnanmentioning
Symptom evaluation and diagnosis in women needs to take hormonal status into account. Consideration should be given to cycle-modulated neuroleptic dosing and to careful titration during pregnancy, postpartum, and at menopause. We recommend that discretionary use of newer neuroleptic medication and adjuvant estrogen therapy be considered.
“…Chang and Renshaw reported an amelioration of symptoms during pregnancy (17). Krener and others found that women with schizophrenia received and required less medication to control their thought disorder when they were pregnant (18). W Can J Psychiatry, Vol 47, No 5, June 2002…”
Section: Symptom Variation Across the Menstrual Cycle During Pregnanmentioning
Symptom evaluation and diagnosis in women needs to take hormonal status into account. Consideration should be given to cycle-modulated neuroleptic dosing and to careful titration during pregnancy, postpartum, and at menopause. We recommend that discretionary use of newer neuroleptic medication and adjuvant estrogen therapy be considered.
“…The hypothesis about the protective effects of estrogens is bolstered by the observation that in pregnancy, when estrogen levels are steadily rising, women who have had recurrent acute episodes of schizophrenia do not usually break down (59,60). However, they do suffer postpartum psychoses when estrogen levels have abruptly plummeted (61).…”
Estrogens are neuroprotective with respect to neuronal degeneration, growth, and susceptibility to toxins. The cyclic fluctuations of estrogens and progesterone enhance the response to stress, which confers susceptibility to depression and anxiety.
“…A traditional view is that pregnancy may protect against recurrence of major affective disorders or suicide. Recurrences of mania and bipolar depression are not uncommon during pregnancy (18)(19)(20)(21), and lithium has been used safely during pregnancy by many patients (22)(23)(24)(25). Recurrences of mania and bipolar depression are not uncommon during pregnancy (18)(19)(20)(21), and lithium has been used safely during pregnancy by many patients (22)(23)(24)(25).…”
Rates of recurrence during the first 40 weeks after lithium discontinuation were similar for pregnant and nonpregnant women but then sharply increased postpartum. Risk was much lower during preceding treatment and less with gradual discontinuation. Treatment planning for potentially pregnant women with bipolar disorder should consider the relative risks of fetal exposure to mood stabilizers versus the high recurrence risks after discontinuing lithium.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.